Arkolith/Insider Trading/RPTX/Form 4

Zinda Michael

EVP, Chief Scientific OfficerRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Jun 7, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 6, 2023Sell(S)1K$12.04$14K69K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-035135) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML